Navigation Links
SureClinical Announces SureClinical Certified Cloud™ for North America and Europe
Date:11/28/2013

al operations business processes to the cloud without compromising security, performance, or reliability, while at the same time maintaining compliance with government regulatory requirements. We are committed to helping BioPharma firms enhance operational efficiency through the cloud," said Zachariah Schmidt, President and CEO, SureClinical.

With the SureClinical Certified Cloud platform and SureClinical’s SureTrial suite of clinical applications, SureClinical provides BioPharma organizations with a secure, agency compliant platform that helps them to realize new operational efficiencies.

SureClinical Certified Cloud Compliance and Security Features

The combination of SureClinical’s Certified Cloud platform and its SureTrial eTMF application suite provides the premier product, support and services clinical trial organizations need to transition to the cloud, while addressing the demanding and unique security, compliance and operational requirements of the BioPharma sector. SureClinical Certified Cloud supports industry compliance. A partial set of cloud compliance and security features are listed below:

  • Physical segregation of customer data: SureClinical has optimized its fast virtualized server environment to ensure rapid deployment while meeting the most strenuous requirements of FDA 21 CFR Part 11 for protection of clinical trial data. SureClinical’s physical segregation of customer data approach maximizes the efficiency of cloud infrastructure while delivering the highest levels of cloud data privacy and security.
  • Two-factor authentication: SureClinical’s Certified Cloud provides integrated two-factor authentication for electronic signing (pat pending) as well as strong authentication techniques to verify user identification and limit system access per FDA and EU regulations.
  • FIPS-140-2 Level 3 compliance: SureClinical’s Certified Cloud is the first cloud solution for h
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SureClinical Announces SurePortal™, First 100% Paperless eTMF Investigator Portal for Automated Document Completion Across Mobile, Web
2. SureClinical Completes FDA 21 CFR Part 11 Compliance Audit of SureTrial® eTMF Cloud Edition
3. GLM Displays Announces Sale on Popular Mosquito 800 Retractable Banner Stand
4. Medrio Announces Advanced Research Associates to Join Partner Program
5. Sangamo BioSciences Announces Presentation At The 25th Annual Piper Jaffray Healthcare Conference
6. Elsevier Announces the Launch of Open Access Journal: Case Studies in Construction Materials
7. RPS Announces FDA Clearance of Rapid, Point-of-Care Test for Dry Eye Disease – InflammaDry®
8. Goodmark Medical announces joining the American Chiropractic Association’s (ACA) Corporate Member Program
9. ISPE Announces Recipients of 2013 International Honor Awards at Global Annual Meeting
10. Ceres Announces Fiscal Year 2013 Financial Results
11. National Association of Professional Women Announces Michelle Doss, Director, Fujifilm Diosynth Biotechnology, as VIP Woman of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... DIEGO , July 28, 2015  Kerastem Technologies ... approval from the U.S. FDA Center For Biologics Evaluation ... Therapies to conduct a clinical trial investigating the safety ... of female and early male pattern baldness (androgenic alopecia). ... STYLE trial, follows initial clinical work in ...
(Date:7/28/2015)... N.C., July 28, 2015  United Therapeutics Corporation (NASDAQ: ... for the second quarter ended June 30, 2015. ... compared to the second quarter of 2014 when ... Ph.D., United Therapeutics, President and Co-Chief Executive Officer. ... an increase in the number of patients being ...
(Date:7/27/2015)... EDMONTON , July 27, 2015 /PRNewswire/ - Quest ... pharmaceutical company developing and commercializing products for the treatment ... Quest announces that it has closed a $1,000,000 ... private placement of 16,666,667 units of the Company at ... comprised of one common share and one common share ...
(Date:7/27/2015)... 2015 Research presented at the 2015 AACC ... the studies that led to a fingerprick Ebola test ... disease to receive approval from the World Health Organization ... grip on West Africa by ... workers to isolate and treat these patients much faster ...
Breaking Biology Technology:Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Quest PharmaTech Closes $1,000,000 Private Placement 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... "Anatomy of a Deal - BioMS Medical and ... /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS),a leading developer ... Mr. Kevin Giese, President and CEO, BioMS Medical and ... and,Company, will take part in a speciality panel session ...
... May 1 Osteotech, Inc.,(Nasdaq: OSTE ), a ... healing, announced today that revenue for the first quarter ... for the first,quarter of 2007. Revenue from the Company,s ... was $17.6 million for the three,months ended March 31, ...
... - AEterna Zentaris Inc.,(NASDAQ: AEZS , TSX: ... and oncology, will announce its first quarter 2008,financial ... May 7,2008. The Company will host a conference ... same day at 4:00 p.m., Eastern Time., ...
Cached Biology Technology:BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008 2BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008 3Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 2Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 3Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 4Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 5
(Date:7/13/2015)... JOSE, Calif. , July 13, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... generation touch and display driver integration (TDDI) product ... is the first to combine Synaptics , ... with proven display driver technology developed in the ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... in Nature Genetics on Sunday 16 September 2007 show that ... genetic variation in regions that control activity of genes, rather ... This surprising result comes from a study at the Wellcome ... in 270 DNA samples collected for the HapMap Project. The ...
... where the Andes meet the Amazon and is locally grown ... the Pacific. It is produced in three species which are ... has resulted in fertile and stable hybrids. This gives it ... quality food production and offer a sustainable cropping system that ...
... known to underlie many human diseases including atherosclerosis, Parkinson,s ... Boston College has found a means to discover more ... of diseases by studying it at the sub-cellular level. ... come primarily from studies using reactive oxygen species (ROS) ...
Cached Biology News:The importance of gene regulation for common human disease 2Yam bean a nearly forgotten crop 2Boston College profs study oxidative stress subcellular to discover its role in diseases 2
... XpressPack Luminescent Detection System is intended for ... DNA generated by an in-house validated method ... a selected target of interest. ... System is a hybridization capture assay designed ...
... System is optimized for maximum packaging efficiencies of ... bacteriophage l vector. Using a test insert with ... arms (> 4 x 10^8 pfu/g ligated l ... is extremely easy to use; simply add up ...
Gridded Cell Culture Petri Dish (20 mm molded in base), tissue-culture treated...
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
Biology Products: